RE:RE:The future of testing.It must be a challenge! You're either pumping THRM or slagging it ....you should check out your own series of posts. I'm sorry you got burned with SONA ...but that's no reason to try to get shares for THRM any cheaper than they already are. Where did the Ebola and HIV segue come from?
How do you anticipate they could develop vaccines faster? Developing vaccines for Covid took 1/10 the time as has been traditionally taken ....and it will still take well into 2022 to vaccinate everyone.
The reality is if AcuVid passes the test hurdle (and there is nothing to suggest it shouldn't) ...THRM will have taken a monumental step closer to approval and manufacturing. There is NOTHING in any of the recent NRs or in comparing AcuVid to the other rapid tests approved to date that would lead to any other conclusion. When it does you'll be sorry you didn't just get the shares at their current price.
GLTY ...and GLTA those holding patiently.
hemi3tc wrote: It will cost u alot of money to test yourself even once a week for all the virises out there. So are u getting tested for Ebola and HiV. Governments will only give u a vaccine since its quicker and cheaper. Like that last SARs outbreak governments were ready for another Pandemic . But after many years started closing those initiatives down since most governments could not afford to maintain them. Now all the experts are talking gotta be ready for the next one and develop vaccines faster. VACCINES not testong.
MarkAble wrote: Covid 19 and its variants will be with the world for many, many years. Constant testing, isolating and yearly or bi yearly and even regional focused vaccine tweaking and booster shots will be required to tamp down the virus. Eventually, hopefully the virulence of Covid 19 will wane and it will become in ten or twenty or thirty years a much less severe disease, perhaps more of an annoyance like the common cold. Until this time however the need for rapid testing across the world will be an essential part of winning the battle. ThermaBright could well be one stock that every investor wished they owned.